Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gessain, A.
Right arrow Articles by Sigaux, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gessain, A.
Right arrow Articles by Sigaux, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis

A Gessain, F Saal, O Gout, MT Daniel, G Flandrin, G de The, J Peries and F Sigaux

Laboratoire d'Hematologie Moleculaire, Hopital Saint-Louis, France.

Human T-cell lymphotropic virus type I (HTLV-I) proviral integration status was examined by Southern blot analysis in peripheral blood mononuclear cell (PBMC) DNA from patients presenting a tropical spastic paraparesis (TSP) and serological evidence of HTLV-I infection. Surface phenotype and morphological aspects of PBMC were also studied. A polyclonal HTLV-I proviral integration was found in the PBMC of the 10 patients studied irrespective of their geographical origin (French West Indies, French Guiana, and Africa), the duration of their clinical illness, or the HTLV-I antibody titer. Furthermore, by dilution experiments and hypothesizing that only one copy of HTLV-I proviral DNA is present in one cell, we estimated that this HTLV-I integration is present in 3% to 15% of their PBMC. All 10 TSP/HTLV-I patients studied had an average of 10% of their lymphocytes abnormal, presenting either a misshapen nucleus or an adult T-cell leukemia/lymphoma (ATL)-like feature. Moreover, an elevated CD4/CD8 ratio associated with the presence of activated T cells with a high level of DR expression was observed in most patients. The significant frequency of viral-positive PBMC and the important load of HTLV-I proviral DNA that we observed in TSP/HTLV-I patients might play an important role in the pathogenesis of this recently identified clinico-virological entity.

Volume 75, Issue 2, pp. 428-433, 01/15/1990
Copyright © 1990 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
N. Dumais, M.-E. Pare, S. Mercier, S. Bounou, S. J. Marriot, B. Barbeau, and M. J. Tremblay
T-Cell Receptor/CD28 Engagement When Combined with Prostaglandin E2 Treatment Leads to Potent Activation of Human T-Cell Leukemia Virus Type 1
J. Virol., October 15, 2003; 77(20): 11170 - 11179.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Koiwa, A. Hamano-Usami, T. Ishida, A. Okayama, K. Yamaguchi, S. Kamihira, and T. Watanabe
5'-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo
J. Virol., August 12, 2002; 76(18): 9389 - 9397.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Yamano, M. Nagai, M. Brennan, C. A. Mora, S. S Soldan, U. Tomaru, N. Takenouchi, S. Izumo, M. Osame, and S. Jacobson
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP)
Blood, January 1, 2002; 99(1): 88 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Mortreux, M. Kazanji, A.-S. Gabet, B. de Thoisy, and E. Wattel
Two-Step Nature of Human T-Cell Leukemia Virus Type 1 Replication in Experimentally Infected Squirrel Monkeys (Saimiri sciureus)
J. Virol., January 15, 2001; 75(2): 1083 - 1089.
[Abstract] [Full Text]


Home page
J. Clin. Pathol.Home page
C. R M Bangham
HTLV-1 infections
J. Clin. Pathol., August 1, 2000; 53(8): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P Cabre, D Smadja, A Cabié, and C R J C Newton
NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: HTLV-1 and HIV infections of the central nervous system in tropical areas
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 550 - 557.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. J. M. Jeffery, K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, et al.
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
PNAS, March 30, 1999; 96(7): 3848 - 3853.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Eiraku, R. Hingorani, S. Ijichi, K. Machigashira, P. K. Gregersen, J. Monteiro, K. Usuku, S. Yashiki, S. Sonoda, M. Osame, et al.
Clonal Expansion Within CD4+ and CD8+ T Cell Subsets in Human T Lymphotropic Virus Type I-Infected Individuals
J. Immunol., December 15, 1998; 161(12): 6674 - 6680.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H.-C. Lin, C. S. Dezzutti, R. B. Lal, and A. B. Rabson
Activation of Human T-Cell Leukemia Virus Type 1 tax Gene Expression in Chronically Infected T Cells
J. Virol., July 1, 1998; 72(7): 6264 - 6270.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. L. Tarsis, M.-T. Yu, E. S. Parks, D. Persaud, J. L. Munoz, and W. P. Parks
Human T-Lymphocyte Transformation with Human T-Cell Lymphotropic Virus Type 2
J. Virol., January 1, 1998; 72(1): 841 - 846.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.H. Richardson, P. Hollsberg, A. Windhagen, L.A. Child, D.A. Hafler, and A.M.L. Lever
Variable Immortalizing Potential and Frequent Virus Latency in Blood-Derived T-Cell Clones Infected With Human T-Cell Leukemia Virus Type I
Blood, May 1, 1997; 89(9): 3303 - 3314.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
H. Nakamura, K. Eguchi, T. Nakamura, A. Mizokami, S. Shirabe, A. Kawakami, N. Matsuoka, K. Migita, Y. Kawabe, and S. Nagataki
High prevalence of Sjogren's syndrome in patients with HTLV-I associated myelopathy
Ann Rheum Dis, March 1, 1997; 56(3): 167 - 172.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1990 by American Society of Hematology         Online ISSN: 1528-0020